ΠΠ·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π³ΠΈΠ±Π΅Π»ΠΈ, ΠΎΠΏΠΎΡΡΠ΅Π΄ΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ°ΠΌΠΈ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° TNF-Rs
ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΌΡΡΠ» ΡΡΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ½ΠΎΠ³ΠΎΠΎΠ±ΡΠ°Π·Π½ΡΡ ΠΈ Π²Π·Π°ΠΈΠΌΠΎΠ·Π°Π²ΠΈΡΠΈΠΌΡΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΠΈΡΠΎΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠ³Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ, ΠΏΠΎ-Π²ΠΈΠ΄ΠΈΠΌΠΎΠΌΡ, Π² ΡΡΡΠΎΠ³ΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π³ΠΈΠ±Π΅Π»ΠΈ Π² ΠΌΠ½ΠΎΠ³ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΌ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅. Π‘ΠΎΠ²ΠΎΠΊΡΠΏΠ½ΠΎΡΡΡ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΡΠ΅Π°ΠΊΡΠΈΠΉ, ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡΠΈΡ ΠΊ Π³ΠΈΠ±Π΅Π»ΠΈ ΡΠ΅Ρ ΠΈΠ»ΠΈ ΠΈΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ, Π²ΠΊΠ»ΡΡΠ°Π΅Ρ Π² ΡΠ΅Π±Ρ, ΠΏΠΎ-Π²ΠΈΠ΄ΠΈΠΌΠΎΠΌΡ, Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ ΡΠ»ΠΈΠΌΠΈΠ½Π°ΡΠΈΡ Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ, ΡΡΠΎ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ Π΄Π»Ρ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠ°Π½ΠΈΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Adam, D., Adam-Klages, S., Kronke, M. Identification of p55 tumor necrosis factor receptor-associated proteins that couple to signaling pathways not initiated by the death domain// J. Inflamm. 1995−1996a — v. 47, № 1−2 — P. 61−66.
- Adam, D., Wiegmann, K., Adam-Klages, S., Ruff, A., Kronke, M. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway.// J. Biol. Chem. 1996b — v. 271, № 24 — P. 46 174 622.
- Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., Kronke, M. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase.// Cell 1996 — v. 86, № 6 — P. 937−947
- Aderka, D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors.// Cytokine Growth Factor Rev. 1996 — v. 3 — P.231−240.
- Aggarwal, B.B., Singh, S., LaPushin, R., Totpal, K. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor// FEBS Lett. 1995 — v. 364, № 1 — P. 5−8.
- Alcami, A., Khanna, A., Paul, N.L., Smith, G.L. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors// J. Gen. Virol. 1999 — v. 80, Pt. 4 — P. 949−959.
- Ashkenazi, A., Dixit, V.M. Death receptors: signaling and modulation// Science -1998-v. 281, № 5381 -p. 1305−1308.
- Atkinson, E.A., Ostergaard, H., Kane, K., Pinkoski, M.J., Caputo, A., Olszowy, M.W., Bleackley, R.C. A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT.// J. Biol. Chem. 1996 — v. 271, № 11 — P. 5968−5971.
- Ausubel, F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K., Albright L.M., Coen D.M., Varki A.(eds.) Current protocols in molecular biology.// Greene Publishing Associates. Wiley & Sons, Inc., N.-Y., 1994.
- Baker, S.J., Reddy, E.P. Modulation of life and death by the TNF receptor superfamily// Oncogene 1998 — v. 17, № 25 — P. 3261−3270.
- Balachandran, S., Kim, C.N., Yeh, W.C., Mak, T.W., Bhalla, K., Barber, G.N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling.// EMBO J. 1998 — v. 17, № 23 — P. 6888−6902.
- Bazzoni, F., Alejos, E., Beutler, B. Chimeric tumor necrosis factor receptors with constitutive signaling activity.// Proc. Natl. Acad. Sci. USA 1995 — v. 92, № 12 -P. 5376−5380.
- Benedict, M.A., Hu, Y., Inohara, N., Nunez, G. Expression and functional analysis of apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9.// J. Biol. Chem. 2000 — v. 275, № 12 — P. 8461−8468.
- Bigda, J., Beletsky I., Brakebusch C., Varfolomeev E., Engelman H., Bigda J., Holtmann H., Wallach D. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.// J. Exp. Med. 1994 — v. 180, № 2 — P. 445−460.
- Blotta, M.H., Marshall, J.D., DeKruyff R.H., Umetsu, D.T. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis// J. Immunol. -1996 v. 156, № 9 — P. 31 333 140.
- Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., Wallach, D. Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death// Cell 1996 — v. 85, № 6 — P. 803−815.
- Boldin, M.P., Mett, I.L., Wallach, D. A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'.// FEBS Lett. 1995 — v. 367, № 1 — 39−44.
- Bono, F., Lamarche, I., Bornia, J., Savi, P., Delia Valle, G., Herbert, J.M. Nerve growth factor (NGF) exerts its pro-apoptotic effect via the P75NTR receptor in a cell cycle-dependent manner// FEBS Lett. 1999 — v. 457, № 1 — P. 93−97.
- Bowman, M.R., Crimmins, M.A., Yetz-Aldape, J., Kriz, R., Kelleher, K., Herrmann, S. The cloning of CD70 and its identification as the ligand for CD27// J. Immunol. 1994 — v. 152, № 4 — P. 1756−1761.
- Brakebusch, C., Nophar, Y., Kemper, O., Engelmann, H., Wallach, D. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.// EMBO J. 1992 -v. 11,№ 3 -P.943−950.
- Brakebusch, C., Varfolomeev, E.E., Batkin, M., Wallach, D. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor.// J. Biol. Chem. 1994 — v. 269, № 51 — P. 32 488−32 496.
- Brenner, B., Ferlinz, K., Grassme, H., Weller, M., Koppenhoefer, U., Dichgans, J., Sandhoff, K., Lang, F., Gulbins, E. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases.// Cell Death Differ. 1998 — v. 5, № 1 — P. 29−37.
- Brink, R., Lodish, H.F. Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domainthat inhibits TNFR2-mediated NF-kappaB activation.// J. Biol. Chem, 1998 — v. 273, № 7-P. 4129−4134.
- Brojatsch, J., Naughton, J., Rolls, M.M., Zingler, K., Young, J.A. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis// Cell 1996 — v. 87, № 5 — P. 845−855.
- Brown, G.R., Meek, K" Nishioka, Y" Thiele, D.L. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes// J. Immunol. 1995 — v. 154, № 8 — P. 3686−3695.
- Brown, J.P., Wei, W., Sedivy, J.M. Bypass of senescence after disruption of p21CIPl/WAFl gene in normal diploid human fibroblasts.// Science 1997 — v. 277,№ 5327-P. 831−834.
- Brustugun, O.T., Fladmark, K.E., Doskeland, S. O,. Orrenius, S., Zhivotovsky, B. Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2.// Cell Death Differ. 1998 — v. 5, № 8 — P. 660−668.
- Carpentier, I., Beyaert, R. TRAF1 is a TNF inducible regulator of NF-kappaB activation.// FEBS Lett. 1999 — v. 460, № 2 — P. 246−250.
- Casaccia-Bonnefil, P., Kong, H., Chao, M.V. Neurotrophins: the biological paradox of survival factors eliciting apoptosis// Cell Death. Differ. 1998 — v. 5, № 5-P. 357−364.
- Cascino, I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecules are produced by alternative splicing.// J. Immunol. 1995 — V. 154, № 6 — P. 2706−2713.
- Cayabyab, M., Phillips, J.H., Lanier, L.L. CD40 preferentially costimulates activation of CD4+ T lymphocytes.// J. Immunol. 1994 — v. 152, № 4 — P. 15 231 531.
- Cecconi, F., Alvarez-Bolado, G., Meyer, B.I., Roth, K.A., Gruss, P. Apafl (CED-4 homolog) regulates programmed cell death in mammalian development.// Cell -1998-v. 94, № 6 P. 727−737.
- Chan, F.K., Chun, H.J., Zheng, L., Siegel, R.M., Bui, K.L., Lenardo, M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.// Science 2000 — v. 288, № 5475 — P. 2351−2354.
- Chan, F.K., Lenardo, M.J. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes.// Eur. J. Immunol. 2000 — v. 30, № 2-P. 652−660.
- Chang, H.Y., Nishitoh, H., Yang, X., Ichijo, H., Baltimore, D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx.// Science 1998-v. 281, № 5384-P. 1860−1863.
- Chaudhary, P.M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., Hood, L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway// Immunity 1997 — v. 7,№ 6−821−830.
- Chen, N.J., Huang, M.W., Hsieh, S.L. Enhanced secretion of IFN-gamma by activated Thl cells occurs via reverse signaling through TNF-related activation-induced cytokine.// J. Immunol. 2001 — v. 166, № 1 — P. 270−276.
- Cheng, E.H., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi, A., Ueno, K., Hardwick, J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases// Science 1997 — v. 278, № 5345 — P. 1966−1968.
- Cheng, G., Baltimore, D. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.// Genes Dev. 1996 — v. 10, № 8 — P. 963−973.
- Cheng, J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.// Science 1994 — V. 263 — P. 1759−1762.
- Chinnaiyan, A.M., O’Rourke, K., Tewari, M., Dixit, V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.// Cell 1995 — v. 81, № 4 — P. 505−512.
- Chinnaiyan, A.M., O’Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J., Dixit, V.M. Signal transduction by DR3, a deathdomain-containing receptor related to TNFR-1 and CD95// Science 1996 — v. 274, № 5289 — P. 990−992.
- Chou, J.J., Li, H., Salvesen, G.S., Yuan, J., Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling.// Cell 1999 — v. 96, № 5 — P. 615−624.
- Chow, V.T., Lim, K.M., Lim, D. The human DENN gene: genomic organization, alternative splicing, and localization to chromosome 1 lpl 1.21-pi 1.22.// Genome -1998 v. 41, № 4 — P. 543−552.
- Chu, K., Niu, X., Williams, L.T. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis.// Proc. Natl. Acad. Sei. USA 1995 — v. 92, № 25 — P. 11 894−11 898.
- Cohen, G.M. Caspases: the executioners of apoptosis// Biochem. J. 1997 — v. 326, Pt. 1 -P. 1−16.
- Cunnion, K.M. Tumor necrosis factor receptors encoded by poxviruses.// Mol. Genet. Metab. 1999 — v. 67, № 4 — P. 278−282.
- DeBenedette, M.A., Chu, N.R., Pollok, K.E., Hurtado, J., Wade, W.F., Kwon, B.S., Watts, T.H. Role of 4−1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP// J. Exp. Med. 1995 — v. 181, № 3-P. 985−992.
- Declercq, W., Denecker, G., Fiers, W., Vandenabeele, P. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.// J. Immunol. 1998 — v. 161, № 1 -P. 390−399.
- Desbarats, J., Duke, R.C., Newell, M.K. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.// Nat. Med. 1998 — v. 4, № 12 — P. 13 771 382.
- Desterro, J.M., Rodriguez, M.S., Hay, R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.// Mol. Cell 1998 — v. 2, № 2 — P. 233−239.
- Dormann, S., Bauer, G. TGF-beta and FGF-trigger intercellular induction of apoptosis: analogous activity on non-transformed but differential activity on transformed cells// Int. J. Oncol. 1998 — v. 13, № 6 — P. 1247−1252.
- Eberstadt, M., Huang, B., Chen, Z., Meadows, R.P., Ng, S.C., Zheng, L., Lenardo, M.J., Fesik, S.W. NMR structure and mutagenesis of the FADD (Mortl) death-effector domain// Nature 1998 — v. 392, № 6679 — P. 941−945.
- Eguchi, Y., Srinivasan, A., Tomaselli, K.J., Shimizu, S., Tsujimoto, Y. ATP-dependent steps in apoptotic signal transduction.// Cancer Res. 1999 — v. 59, № 9-P. 2174−2181.
- Eissner, G., Kirchner, S., Lindner, H., Kolch, W., Janosch, P., Grell, M., Scheurich, P., Andreesen, R., Holler, E. Reverse signaling through transmembrane
- TNF confers resistance to lipopolysaccharide in human monocytes and macrophages.// J. Immunol. 2000 — v. 164, № 12 — P. 6193−6198.
- Eskes, R., Desagher, S., Antonsson, B., Martinou, J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane.// Mol. Cell. Biol. 2000 — v. 20, № 3 — P. 929−935.
- Estelles, A., Charlton, C.A., Blau, H.M. The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis.// Dev. Biol. 1999 — v. 216, № 1 — P. 16−28.
- Everett, R.D., Earnshaw, W.C., Pluta, A.F., Sternsdorf, T., Ainsztein, A.M., Carmena, M., Ruchaud, S., Hsu, W.L., Orr, A. A dynamic connection between centromeres and ND10 proteins.// J. Cell Sci. 1999 — v. 112, Pt 20 — P. 34 433 454.
- Fisher, D.E. Apoptosis in cancer therapy: crossing the threshold// Cell 1994 — v. 78, № 4 — P. 539−542.
- Frade, J.M., Barde, Y.A. Nerve growth factor: two receptors, multiple functions// Bioessays 1998 — v. 20, № 2 — P. 137−145.
- Freiberg, R.A., Spencer, D.M., Choate, K.A., Duh, H.J., Schreiber, S.L., Crabtree, G.R., Khavari, P.A. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts.// J. Invest. Dermatol. 1997 — v. 108, № 2 — P. 215−219.
- Golstein, P., Marguet, D., Depraetere, V. Homology between reaper and the cell death domains of Fas and TNFR1.// Cell 1995 — v. 81, № 2 — P. 185−186.
- Gong, L., Kamitani, T., Fujise, K., Caskey, L.S., Yeh, E.T.H. Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9.// J. Biol. Chem. 1997 — v. 272, № 45 — P. 28 198−28 201.
- Gong, L., Millas, S., Maul, G.G., Yeh, E.T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease.// J. Biol. Chem. 2000 -v. 275,№ 5 -P. 3355−3359.
- Gonzalez, M., Mackay, F., Browning, J.L., Kosco-Vilbois, M.H., Noelle, R.J. The sequential role of lymphotoxin and B cells in the development of splenic follicles// J. Exp. Med. 1998 — v. 187, № 7 — P. 997−1007.
- Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S.E., Scheffner, M., Del Sal, G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.// EMBO J. 1999 — v. 18, № 22 — P. 6462−6471.
- Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD 120a) is the high-affinity receptor for soluble tumor necrosis factor.// Proc. Natl. Acad. Sei. USA- 1998 v. 95, № 2 — P. 570−575.
- Grell, M., Becke, F.M., Wajant, H., Mannel, D.N., Scheurich, P. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type III Eur. J. Immunol. 1998 — v. 28, № 1-P. 257−263.
- Grell, M., Zimmermann, G., Gottfried, E., Chen, C.M., Grunwald, U., Huang, D.C., Wu Lee, Y.H., Durkop, H., Engelmann, H., Scheurich, P., Wajant, H., Strasser, A. Induction of cell death by tumour necrosis factor (TNF) receptor 2,
- CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.// EMBO J. 1999 — v. 18, № 11 — P. 3034−3043.
- Grenet, J., Valentine, V., Kitson, J., Li, H" Farrow, S.N., Kidd, V.J. Duplication of the DR3 gene on human chromosome lp36 and its deletion in human neuroblastoma// Genomics 1998 — v. 49, № 3 — P. 385−393.
- Grimm, S., Stanger, B.Z., Leder, P. RIP and FADD: two «death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways.// Proc. Natl. Acad. Sei. U S A 1996 — v. 93, № 20 — P. 10 923−10 927.
- Gruss, H.J., Boiani, N., Williams, D.E., Armitage, R.J., Smith, C.A., Goodwin, R.G. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines// Blood 1994 — v. 83, № 8 — P.2045−2056.
- Halenbeck, R., MacDonald, H., Roulston, A., Chen, T.T., Conroy, L., Williams, L.T. CP AN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45// Curr. Biol. 1998 — v. 8, № 9 — P. 537−540.
- Han, J.S., Hyun, B.C., Kim, J.H., Shin, I. Fas-mediated activation of phospholipase D is coupled to the stimulation of phosphatidylcholine-specific phospholipase C in A20 cells.// Arch. Biochem. Biophys. 1999 — v. 367, № 2 -P. 233−239.
- Hane, M., Lowin, B., Peitsch, M., Becker, K., Tschopp, J. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain.// FEBS Lett. -1995 v. 373, № 3 — P. 265−268.
- Hildt, E., Oess, S. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.// J. Exp. Med. 1999 — v. 189, № 11 — P. 17 071 714.
- Hingorani, R., Bi, B., Dao, T., Bae, Y., Matsuzawa, A., Crispe, I.N. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-l/WAF-, which promotes apoptosis.// J. Immunol. 2000 — v. 164, № 8 — P. 4032−4036.
- Hoeflich, K.P., Yeh, W.C., Yao, Z., Mak, T.W., Woodgett, J.R. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1).// Oncogene 1999-v. 18, № 42 — 5814−5820.
- Hofmann, K., Bucher, P., Tschopp, J. The CARD domain: a new apoptotic signalling motif// Trends Biochem. Sci. 1997 — v. 22, № 5 — P. 155−156.
- Hohlbaum AM, Moe S, Marshak-Rothstein A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.// J. Exp. Med. 2000 — v. 191, № 7 — P. 1209−1220.
- Hollenbach, A.D., Sublettl, J.E., McPherson C.J., Grosveld, G. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx.// EMBO J. 1999-v. 18-P. 3702−3711.
- Holtmann, H., Wallach, D. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.// J. Immunol. 1987-v. 139,№ 4-P. 1161−1167.
- Hsu, H., Huang, J., Shu, H.B., Baichwal, V., Goeddel, D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.// Immunity 1996 — v. 4, № 4 — P. 387−396.
- Hsu, H., Shu, H.B., Pan, M.G., Goeddel, D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.// Cell 1996 — v. 84, № 2 — P. 299−308.
- Hsu, H., Xiong, J., Goeddel, D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.// Cell 1995 — v. 81, № 4 — P. 495−504.
- Hu, S., Tamada, K., Ni, J., Vincenz, C., Chen, L. Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily.// Genomics 1999-v. 62, № 1 — P. 103−107.
- Hu, Y., Benedict, M.A., Ding, L., Nunez, G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis.// EMBO J. 1999 — v. 18, № 13 — P. 3586−3595.
- Huang, B., Eberstadt, M., Olejniczak, E.T., Meadows, R.P., Fesik, S.W. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain// Nature 1996 -v. 384,№ 6610-P. 638−641.
- Hurtado, J.C., Kim, S.H., Pollok, K.E., Lee, Z.H., Kwon, B.S. Potential role of 4−1BB in T cell activation. Comparison with the costimulatory molecule CD28// J. Immunol. 1995 — v. 155, № 7 — P. 3360−3367.
- Itoh, N., Nagata, S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen// J. Biol. Chem. 1993 — v. 268, № 15 — P. 1 093 210 937.
- Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis// Cell 1991 — v. 66, № 2 -P.233−243.
- Jelaska, A., Korn, J.H. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts.// J. Cell. Physiol. 1998 — v. 175, № 1 — P. 19−29.
- Jiang, Y., Woronicz, J.D., Liu, W., Goeddel, D.V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.// Science 1999 — v. 283, № 5401 -P. 543−546.
- Jones, E.Y., Stuart, D.I., Walker, N.P. Crystal structure of TNF.// Immunol. Ser. 1992-v. 56-P.93−127.
- Juo, P., Kuo, C.J., Yuan, J., Blenis, J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade.// Curr. Biol. -1998-v. 8, № 18-P. 1001−1008.
- Kang, J.H., Shin, I., Han, J.S. Changes of phospholipase D activity in TNF-alpha and anti-Fas/Apol monoclonal antibody induced apoptosis in HL-60 and A20 cells.// Exp. Mol. Med. 1998 — v. 30, № 1 — P. 21−27.
- Kashii, Y., Giorda, R., Herberman, R.B., Whiteside, T.L., Vujanovic, N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.// J. Immunol. 1999 — v. 163, № 10 — P. 53 585 366.
- Kohler, C., Gahm, A., Noma, T., Nakazawa, A., Orrenius, S., Zhivotovsky, B. Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis.// FEBS Lett. 1999 — v. 447, № 1 — P. 10−12.
- Koni, P.A., Sacca, R., Lawton, P., Browning, J.L., Ruddle, N.H., Flavell, R.A. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice// Immunity 1997 — v. 6, № 4 — P. 491−500.
- Koppenhoefer, U., Brenner, B., Lang, F., Gulbins, E. The CD40-ligand stimulates T-lymphocytes via the neutral sphingomyelinase: a novel function of the CD40-ligand as signalling molecule.// FEBS Lett. 1997 — v. 414, № 2 — P. 444−448.
- Korshunov, S.S., Krasnikov, B.F., Pereverzev, M.O., Skulachev, V.P. The antioxidant functions of cytochrome c.// FEBS Lett. 1999 — v. 462, № 1−2 — P. 192−198.
- Krammer, P.H. CD95's deadly mission in the immune system.// Nature 2000 -v. 407, № 6805-P. 789−795.
- Kulmburg, P., Radke, M., Digel, W. Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells// Leukemia 1998 — v. 12, № 4-P. 493−498.
- Kyriakis, J.M., Avruch, J. Protein kinase cascades activated by stress and inflammatory cytokines.// Bioessays 1996 — v. 18, № 7 — P. 567−577.
- Langstein, J., Michel, J., Fritsche, J., Kreutz, M., Andreesen, R., Schwarz, H. CD 137 (ILA/4−1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling.// J. Immunol. 1998 — v. 160, № 5 — P. 2488−2494.
- Lenczowski, J.M., Dominguez, L., Eder, A.M., King, L.B., Zacharchuk, C.M., Ashwell, J.D. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis.// Mol. Cell Biol.-1997-v. 17,№ 1-P. 170−181.
- Levy-Strumpf, N., Kimchi, A. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.// Oncogene- 1998-v. 17, № 25-P. 3331−3340.
- Li, H., Leo, C., Zhu, J., Wu, X., O’Neil, J., Park, E.J., Chen, J.D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.// Mol. Cell Biol. 2000 — v. 20, № 5 — P. 1784−1796.
- Li, H., Zhu, H., Xu, C.J., Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.// Cell 1998 — v. 94, № 4 -P. 491−501.
- Li, R., Pei, H., Watson, D.K., Papas, T.S. EAPl/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.// Oncogene 2000 — v.19, № 6 P. 745−753.
- Li, S.J., Hochstrasser, M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein.// Mol. Cell Biol. 2000 — v.20, № 7 P. 2367−2377.
- Lin, Y., Devin, A., Rodriguez, Y., Liu, Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.// Genes Dev. 1999 -v. 13,№ 19-P. 2514−2526.
- Liou, M.L., Liou, H.C. The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis.// J. Biol. Chem. 1999-v. 274, № 15-P. 10 145−10 153.
- Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W.T., Wang, X. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis// Proc. Natl. Acad. Sci. USA- 1998 -v. 95,№ 15-P. 8461−8466.
- Liu, X., Zou, H., Slaughter, C., Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis// Cell 1997 — v. 89, № 2 — P. 175−184.
- Liu, Z.G., Hsu, H., Goeddel, D.V., Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.// Cell 1996 — v. 87, № 3 — P. 565−576.
- Luo, X., Budihardjo, I., Zou, H» Slaughter, C" Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.// Cell 1998 — v. 94, № 4 — P. 481 490.
- MacFarlane, M., Ahmad, M., Srinivasula, S.M., Fernandes-Alnemri, T., Cohen, G.M., Alnemri, E.S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.// J. Biol. Chem. 1997 — v. 272, № 41 -P.25 417−25 420.
- Mackay, F., Rothe, J., Bluethmann, H., Loetscher, H., Lesslauer, W. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation// J. Immunol. 1994 — v. 153, № 11 -P. 5274−5284.
- Mackay, F., Woodcock, S.A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., Browning, J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.// J. Exp. Med. -1999-v. 190, № 11 P. 1697−1710.
- Malinin, N.L., Boldin, M.P., Kovalenko, A.V., Wallach, D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.// Nature 1997 -v. 385,№ 6616-P. 540−544.
- Marsters, S.A., Sheridan, J.P., Pitti, R.M., Brush, J., Goddard, A., Ashkenazi, A. Identification of a ligand for the death-domain-containing receptor Apo3// Curr. Biol. 1998 — v. 8, № 9 — P. 525−528.
- Martinon, F., Holler, N., Richard, C., Tschopp, J. Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP.// FEBS Lett. 2000 — v. 468, β№ 2−3 — P. 134−136.
- Mason, A.T., McVicar, D.W., Smith, C.A., Young, H.A., Ware, C.F., Ortaldo, J.R. Regulation of NK cells through the 80-kDa TNFR (CD 120b)// J. Leukoc. Biol. 1995 — v. 58, № 2 — P. 249−255.
- Masuda, M., Ishida, C., Arai, Y., Okamura, T., Ohsawa, M., Shimakage, M., Mizoguchi, H. Dual action of CD30 antigen: anti-CD30 antibody induced apoptosis and interleukin-8 secretion in Ki-1 lymphoma cells// Int. J. Hematol.1998-v. 67, № 3-P. 257−265.
- Matsumura, Y., Hori, T., Kawamata, S., Imura, A., Uchiyama, T. Intracellular signaling of gp34, the 0X40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, 0X40.// J. Immunol. 1999 -v. 163,№ 6-P. 3007−3011.
- Matunis, M.J., Coutavas, E., Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAPl between the cytosol and the nuclear pore complex.// J. Cell Biol. 1996 -v. 135 -P.1457−1470.
- McCarthy, J.V., Ni, J., Dixit, V.M. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase.// J. Biol. Chem. 1998 — v. 273, № 27 — P. 1 696 816 975.
- McDonald PP, Fadok VA, Bratton D, Henson PM. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells.// J. Immunol. 1999 -v. 163, № 11 — P. 6164−6172.
- McDonnell, J.M., Fushman, D., Milliman, C.L., Korsmeyer, S.J., Cowburn, D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.// Cell 1999 — v. 96, № 5 — P. 625−634.
- Michaelson, J.S., Bader, D., Kuo, F., Kozak, C., Leder, P. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development.// Genes Dev. 1999 — v. 13, № 15 — P. 1918−1923.
- Montgomery, R.I., Warner, M.S., Lum, B.J., Spear, P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family// Cell 1996 — v. 87, № 3 — P. 427−436.
- Mullins, M.W., Pittner, B.T., Snow, E.C. CD40-mediated induction of p21 accumulation in resting and cycling B cells// Mol. Immunol. 1998 — v. 35, № 10 -P. 567−580.
- Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S., Dixit, V.M. An induced proximity model for caspase-8 activation// J. Biol. Chem. 1998 — v. 273, № 5 — P. 2926−2930.
- Nagata, S. Apoptosis by death factor// Cell 1997 — v. 88, № 3 — P. 355−365
- Nagata, S. Fas-induced apoptosis // Intern. Med. 1998 -v. 37, № 2 — P. 179 181.
- Navas, T.A., Baldwin, D.T., Stewart, T.A. RIP2 is a Rafl-activated mitogen-activated protein kinase kinase.// J. Biol. Chem. 1999 — v. 274, № 47 — P. 33 684−33 690.
- Ng, P.W., Janicke, R.U., Porter, A.G. Mutations which abolish phosphorylation of the TRAF-binding domain of TNF receptor 2 enhance receptor-mediated NF-kappa B activation.// Biochem. Biophys. Res. Commun. -1998-v. 244, № 3 P.756−762.
- Nicholson, D.W., Thornberry, N.A. Caspases: killer proteases// Trends Biochem. Sci. 1997 — v. 22, № 8 — P. 299−306.
- Nicholson, D.W. From bench to clinic with apoptosis-based therapeutic agents.//Nature 2000 — v. 407, № 6805 — P. 810−816.
- Nishitoh, H., Saitoh, M., Mochida, Y., Takeda, K., Nakano, H., Rothe, M., Miyazono, K., Ichijo, H. ASK1 is essential for JNK/SAPK activation by TRAF2.// Mol. Cell 1998 — v. 2, № 3 — P. 389−395.
- Nunez, G., Benedict, M.A., Hu, Y., Inohara, N. Caspases: the proteases of the apoptotic pathway.// Oncogene 1998 — v. 17, № 25 — P. 3237−3245.
- Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., Delespesse, G. Expression and function of 0X40 ligand on human dendritic cells// J. Immunol. 1997-v. 159, № 8 — P. 3838−3848.
- Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C.F., Chang, H.M., Yeh, E.T. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.// J. Immunol. 1996 — v. 157, № 10-P. 4277−4281.
- Okura, T., Igase, M., Kitami, Y., Fukuoka, T., Maguchi, M., Kohara, K., Hiwada, K. Platelet-derived growth factor induces apoptosis in vascular smoothmuscle cells: roles of the Bcl-2 family// Biochim. Biophys. Acta 1998 — v.1403, № 3 — P. 245−253.
- Pan, G., Humke, E.W., Dixit, V.M. Activation of caspases triggered by cytochrome c in vitro// FEBS Lett.- 1998 v. 426, № 1 — P. 151−154.
- Pan, G., O’Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J., Dixit, V.M. The receptor for the cytotoxic ligand TRAIL// Science 1997 — v. 276, № 5309-P. 111−113.
- Park, A., Baichwal, V.R. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD.// J. Biol. Chem. 1996 — v. 271, № 16, — P. 9858−9862.
- Park, Y.C., Burkitt, V., Villa, A.R., Tong, L., Wu, H. Structural basis for self-association and receptor recognition of human TRAF2.// Nature 1999 — v. 398, № 6727-P. 533−538.
- Pettmann, B., Henderson, C.E. Neuronal cell death// Neurone 1998 — v. 20, № 4 — P. 633−647.
- Pimentel-Muinos, F.X., Seed, B. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation// Immunity 1999 — v. 11, № 6-P. 783−793.
- Pinckard, J.K., Sheehan, K.C., Schreiber, R.D. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells.// J. Biol. Chem.- 1997-v. 272,№ 16-P. 10 784−10 789.
- Pluta, A.F., Earnshaw, W.C., Goldberg, I.G. Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death.// J. Cell Sci. 1998 — v. 111, Pt 14 -P. 2029−2041.
- Pollok, K.E., Kim, Y.J., Hurtado, J., Zhou, Z., Kim, K.K., Kwon, B.S. 4−1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells.// Eur. J. Immunol. 1994 — v. 24, № 2 — P. 367−374.
- Pomerantz, J.L., Baltimore, D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.// EMBO J. -1999 v. 18, № 23 — P. 6694−6704.
- Puvion-Dutilleul, F., Venturini, L., Guillemin, M.C., de The, H., Puvion, E. Sequestration of PML and SplOO proteins in an intranuclear viral structure during herpes simplex virus type 1 infection.// Exp. Cell Res. 1995 — v. 221, № 2 — P. 448−461.
- Raff, M.C. Social controls on cell survival and cell death// Nature 1992 — v. 356, № 6368 — P. 397−400.
- Reed, J.C. Bcl-2 family proteins.// Oncogene 1998 — v. 17, № 25 — P. 32 253 236.
- Reinhard, C., Shamoon, B., Shyamala, V., Williams, L.T. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.//EMBO J.- 1997-v. 16, № 5-P. 1080−1092.
- Reiter, I., Krammer, B., Schwamberger, G. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities.// J. Immunol. 1999 — v. 163, № 4-P. 1730−1732.
- Rennert, P.D., Browning, J.L., Mebius, R., Mackay, F., Hochman, P. S. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs// J. Exp. Med. 1996 — v. 184, № 5 — P. 1999−2006.
- Resnitzky, D., Gossen, M., Bujard, H., Reed, S.I. Acceleration of the Gl/S phase transition by expression of cyclins D1 and E with an inducible system.// Mol. Cell. Biol.- 1994-v. 14, № 3-P. 1669−1679.
- Rodriguez, M.S., Desterro, J.M., Lain, S., Midgley, C.A., Lane, D.P., Hay, R.T. SUMO-1 modification activates the transcriptional response of p53.// EMBO J.- 1999-v. 18, № 22-P. 6455−6461.
- Rothe, M., Pan, M.G., Henzel, W.J., Ayres, T.M., Goeddel, D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins.// Cell 1995 — v. 83, № 7 — P. 1243−1252.
- Rothe, M., Wong, S.C., Henzel, W.J., Goeddel, D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.// Cell 1994 — v. 78, № 4 — P. 681−692.
- Rothe, M., Xiong, J., Shu, H.B., Williamson, K., Goddard, A., Goeddel, D.V. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.// Proc. Natl. Acad. Sei. USA 1996 — v. 93, № 16 — P. 8241−8246.
- Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.// EMBO J. 1997 — v. 16, № 23-P. 6914−6925.
- Rudel, T., Zenke, F.T., Chuang, T.H., Bokoch, G.M. p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells.// J. Immunol. -1998-v. 160,№ 1-P.7−11.
- Saleh, A., Srinivasula, S.M., Acharya, S., Fishel, R., Alnemri, E.S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation.// J. Biol. Chem. 1999 — v. 274, № 25 — P. 17 941−17 945.
- Salih, H.R., Kosowski, S.G., Haluska, V.F., Starling, G.C., Loo, D.T., Lee, F., Aruffo, A.A., Trail, P.A., Kiener, P.A. Constitutive expression of functional 4−1BB (CD 137) ligand on carcinoma cells.// J. Immunol. 2000 — v. 165, № 5 — P. 2903−2910.
- Salvesen, G.S., Dixit, V.M. Caspases: intracellular signaling by proteolysis// Cell 1997 — v. 91, № 4 — P. 443−446.
- Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual.// New York: Cold Spring Harbor Laboratory, 1989.
- Samejima, K., Svingen, P.A., Basi, G.S., Kottke, T., Mesner, P.W. Jr., Stewart, L., Durrieu, F., Poirier, G.G., Alnemri, E.S., Champoux, J.J., Kaufmann,
- S.H., Earnshaw, W.C. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis// J. Biol. Chem. 1999 — v. 274, № 7 — P. 4335−4340.
- Sanchez, A., Alvarez, A.M., Lopez Pedrosa, J.M., Roncero, C., Benito, M., Fabregat, I. Apoptotic response to TGF-beta in fetal hepatocytes depends upon their state of differentiation// Exp. Cell Res. 1999 — v. 252, № 2 — P. 281−291.
- Sanger, F., Nicklen, S., Coulson, A.R. DNA sequencing with chain-terminating inhibitors.// Proc. Natl. Acad. Sci. USA- 1977 v. 74, № 12 — P. 5463−5467.
- Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT, Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.// EMBO J. 1999 v. 18,№ 11-P. 3044−3053.
- Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K.M., Krammer, P.H., Peter, M.E. Two CD95 (APO-l/Fas) signaling pathways.// EMBO J. 1998 — v. 17, № 6 — P. 1675−1687.
- Schneider, P., Bodmer, J.L., Thome, M., Hofmann, K., Holler, N., Tschopp, J. Characterization of two receptors for TRAIL// FEBS Lett. 1997 — v. 416, № 3 -P. 329−334.
- Schneider, P., Thome, M., Burns, K., Bodmer, J.L., Hofmann, K., Kataoka, T., Holler, N., Tschopp, J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB// Immunity 1997a — v. 7, № 6 — P. 831−836.
- Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., Peter, M.E. Apoptosis signaling by death receptors// Eur. J. Biochem. 1998 — v. 254, № 3 -P.439−459.
- Schwarz, H., Blanco, F.J., von Kempis, J., Valbracht, J., Lotz, M. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival.// Blood 1996 — v. 87, № 7 -P.2839−2845.
- Seufert, W., Futcher, B., Jentsch, S. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins.// Nature 1995 — v. 373, № 6509 — P. 7881.
- Shanebeck, K.D., Maliszewski, C.R., Kennedy, M. K, Picha, K.S., Smith, C.A., Goodwin, R.G., Grabstein, K.H. Regulation of murine B cell growth and differentiation by CD30 ligand// Eur. J. Immunol. 1995 — v. 25, № 8 — P. 21 472 153.
- Shen, Z., Pardington-Purtymun, P.E., Comeaux, J.C., Moyzis, R.K., Chen, D.J. UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins.// Genomics 1996 — v. 36, № 2 — P. 271−279.
- Shu, H.B., Takeuchi, M., Goeddel, D.V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAPl are components of the tumor necrosis factor receptor 1 signaling complex.// Proc. Natl. Acad. Sci. USA- 1996 v. 93, № 24 -P. 13 973−13 978.
- Skulachev, V.P. Cytochrome c in the apoptotic and antioxidant cascades.// FEBS Lett. 1998 — v. 423, № 3 — P. 275−280.
- Smith, C.A., Farrah, T., Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death// Cell 1994 -v.76, β
- Song, H.Y., Rothe, M., Goeddel, D.V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.// Proc. Natl. Acad. Sci. USA 1996 — v. 93, № 13 — P. 6721−6725.
- Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T., Alnemri, E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.// Mol. Cell -1998-v. 1, № 7 P. 949−957.
- Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.// Cell 1995 — v. 81, № 4 — P. 513−523.
- Steller, H. Mechanisms and genes of cellular suicide// Science 1995 — v. 267, № 5203 — P. 1445−1449.
- Strasser, A., Newton, K. FADD/MORT1, a signal transducer that can promote cell death or cell growth.// Int. J. Biochem. Cell. Biol. 1999 — v. 31, № 5 — P. 533−537.
- Stuber, E., Neurath, M., Calderhead, D., Fell, H.P., Strober, W. Cross-linking of 0X40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells// Immunity 1995 — v. 2, № 5 — P. 507−521.
- Stuber, E., Neurath, M., Calderhead, D., Fell, H.P., Strober, W. Cross-linking of 0X40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells.// Immunity 1995 — v. 2, № 5 — P. 507−521.
- Stuber, E., Strober, W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response// J. Exp. Med. -1996-v. 183, № 3-P. 979−989.
- Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., Nagata, S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing.// J. Exp. Med. 1997 — v. 186, № 12 — P. 2045−2050.
- Sun, X., Lee, J., Navas, T., Baldwin, D.T., Stewart, T.A., Dixit, V.M. RIP3, a novel apoptosis-inducing kinase.// J. Biol. Chem. 1999 — v. 274, № 24 — P. 16 871−16 875.
- Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prevost, M.C., Alzari, P.M., Kroemer, G. Mitochondrial release of caspase-2 and -9 during the apoptotic process// J. Exp. Med. 1999 — v. 189, № 2 — P. 381 394.
- Suzuki, I., Fink, P.J. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells.// Proc. Natl. Acad. Sei. USA.- 2000 v. 97, № 4-P. 1707−1712.
- Suzuki, I., Fink, P.J.Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.// J. Exp. Med. 1998 — v. 187, № 1 -P. 123−128.
- Suzuki, I., Martin, S., Boursalian, T.E., Beers, C., Fink, P.J. Fas ligand costimulates the In vivo proliferation of CD8(+) T cells.// J. Immunol. 2000 — v. 165, № 10-P. 5537−5543.
- Takayama, S., Xie, Z., Reed, J.C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators.// J. Biol. Chem. 1999 — v. 274, № 2-P. 781−786.
- Takeuchi, M., Rothe, M., Goeddel, D.Y. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.// J. Biol. Chem. 1996 — v. 271, № 33 — P. 1 993 519 942.
- Tan, J.T., Whitmire, J.K., Ahmed, R., Pearson, T.C., Larsen, C.P. 4−1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses// J. Immunol. 1999 — v. 163, № 9 — P. 4859−4868.
- Tan, X., Martin, S.J., Green, D.R., Wang, J.Y.J. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death// J. Biol. Chem. -1997 v. 272, № 15 — P. 9613−9616.
- Tanaka, M., Itai, T., Adachi, M., Nagata, S. Downregulation of Fas ligand by shedding.//Nat. Med. 1998 — v. 4, № 1 — P. 31−36.
- Tartaglia, L.A., Ayres, T.M., Wong, G.H., Goeddel, D.V. A novel domain within the 55 kd TNF receptor signals cell death// Cell 1993 — v. 74, № 5 — P. 845−853.
- Tartaglia, L.A., Goeddel, D.V. Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor.// J. Biol. Chem. 1992 — v. 267, № 7 — P. 4304−4307.
- Tartaglia, L.A., Pennica, D., Goeddel, D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.// J. Biol. Chem. 1993 — v. 268, № 25 — P. 18 542−18 548.
- Telford, W.G., Nam, S.Y., Podack, E.R., Miller, R.A. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals // Cell Immunol. -1997-v. 182, № 2 P. 125−136.
- Thompson, C.B. Apoptosis in the pathogenesis and treatment of decease// Science 1995 — v. 267, № 5203 — P. 1456−1462.
- Torii, S., Egan, D.A., Evans, R.A., Reed, J.C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).// EMBO J. -1999-v. 18, № 21-P. 6037−6049.
- Towbin, H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: procedure and some applications.// Proc.Natl.Acad.Sci.USA. 1979 — v. 76, № 9 — P. 4350−4354.
- Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M., Krammer, P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis// Science 1989 — v. 245, № 4915 — P. 301−305.
- Tribouley, C., Wallroth, M., Chan, V., Paliard, X., Fang, E., Lamson, G., Pot, D., Escobedo, J., Williams, L.T. Characterization of a new member of the TNF family expressed on antigen presenting cells.// Biol. Chem. 1999 — v. 380, № 12 -P. 1443−1447.
- Van Kooten, C., Banchereau, J. CD40-CD40 ligand.// J. Leukoc. Biol. 2000 -v. 67, β l p. 2−17.
- Van Parijs, L., Refaeli, Y., Lord, J.D., Nelson, B.H., Abbas, A.K., Baltimore, D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fasmediated activation-induced cell death// Immunity 1999 — v. 11, № 3 — P. 281 288.
- Vandevoorde, V., Haegeman, G., Fiers, W. Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.// J. Cell. Biol. 1997 — v. 137, № 7 — P. 1627−1638.
- Vassilev, A., Ozer, Z., Navara, C., Mahajan, S., Uckun, F.M. Bruton’s tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.// J. Biol. Chem. 1999 — v. 274, № 3 — P. 1646−1656.
- Wallach, D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect.// J. Immunol. 1984 — v. 132, № 5 — P. 2464−2469.
- Wallach, D., Kovalenko, A.V., Varfolomeev, E.E., Boldin, M.P. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict// Curr. Opin. Immunol. 1998 — v. 10, № 3 — P. 279−288.
- Walsh, C.M., Wen, B.G., Chinnaiyan, A.M., O’Rourke, K., Dixit, V.M., Hedrick, S.M. A role for FADD in T cell activation and development.// Immunity 1998 — v. 8, № 4 — P. 439−449.
- Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., Baldwin, A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAPl and C-IAP2 to suppress caspase-8 activation.// Science 1998 — v. 281, № 5383 — P. 1680−1683.
- Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., Korsmeyer, S.J. BID: a novel BH3 domain-only death agonist.// Genes Dev. 1996 — v. 10, № 22 — P. 2859−2869.
- Wen-Hui, H., Holly, J., Hong-Bing, S. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kB and JNK activation and apoptosis through distinct pathways// J. Biol. Chem. 1999 — v. 274, № 43 — P. 30 603−30 610.
- Wiley, S.R., Goodwin, R.G., Smith, C.A. Reverse signaling via CD30 ligand.// J. Immunol. 1996 — v. 157, № 8 — P. 3635−3639.
- Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., Goeddel, D.V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.// Science 1997 — v. 278, № 5339 — P. 866−869.
- Wright, D.A., Futcher, B., Ghosh, P., Geha, R.S. Association of Human Fas (CD95) with a Ubiquitin-conjugating Enzyme (UBC-FAP).// J. Biol. Chem. -1996 v. 271, № 49 — P. 31 037−31 043.
- Wu, M.X., Ao, Z., Prasad, K.V., Wu, R., Schlossman, S.F. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.// Science -1998 v. 281, № 5379 — P. 998−1001.
- Wyllie, A.H., Kerr, J.F.R., Currie, A.R. Cell death: the significance of apoptosis// Int Rev Cytol. 1980 — v. 68 — P. 251−306.
- Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., Beach, D. p21 is a universal inhibitor of cyclin kinases.// Nature 1993 — v. 366, № 6456 — P. 701−704.
- Yang, F.C., Agematsu, K., Nakazawa, T., Mori, T., Ito, S., Kobata, T., Morimoto, C., Komiyama, A. CD27/CD70 interaction directly induces natural killer cell killing activity// Immunology 1996 — v. 88, № 2 — P. 289−293.
- Yang, X., Khosravi-Far, R., Chang, H.Y., Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis.// Cell 1997 — v. 89, № 7 — P. 1067−1076.
- Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S" Klocke, B., Roth, K.A., Korsmeyer, S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.//Nature 1999 — v. 400, № 6747 — P. 886−891.
- Ying, S.Y., Chuong, C.M., Lin, S. Suppression of activin-induced apoptosis by novel antisense strategy in human prostate cancer cells// Biochem. Biophys. Res. Commun. 1999 -v. 265, № 3 — P.669−673.
- Yonehara, S., Ishii, A., Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor// J. Exp. Med. 1989 — v. 169, № 5 — P. 1747−1756.
- Yoshida, H., Kong, Y.Y., Yoshida, R., Elia, A.J., Hakem, A., Hakem, R., Penninger, J.M., Mak, T.W. Apafl is required for mitochondrial pathways of apoptosis and brain development.// Cell 1998 — v. 94, № 6 — P. 739−750.
- Yu, K.Y., Kwon, B" Ni, J., Zhai, Y" Ebner, R" Kwon, B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.// J. Biol. Chem. 1999 — v. 274, № 20 — P. 1 373 313 736.
- Yu, P.W., Huang, B.C., Shen, M" Quast, J., Chan, E., Xu, X., Nolan, G.P., Payan, D.G., Luo, Y. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB.// Curr. Biol. 1999 — v. 9, № 10 — P. 539−542.
- Zhang, H.G., Su, X., Liu, D" Liu, W., Yang, P., Wang, Z" Edwards, C.K., Bluethmann, H., Mountz, J.D., Zhou, T. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.// J. Immunol. 1999 — v. 162, № 3 -P. 1423−1430.
- Zhivotovsky, B., Gahm, A., Orrenius, S. Two different proteases are involved in the proteolysis of lamin during apoptosis// Biochem. Biophys. Res. Commun. -1997-v. 233, № 1 P. 96−101.
- Zhivotovsky, B., Orrenius, S., Brustugun, O.T., Doskeland, S.O. Injected cytochrome c induces apoptosis.// Nature 1998 — v. 391, № 6666 — P. 449−450.
- Zhivotovsky, B., Samali, A., Gahm, A., Orrenius, S. Caspases: their intracellular localization and translocation during apoptosis.// Cell Death Differ. -1999-v. 6, № 7 P. 644−651.
- Zhong, S., Salomoni, P., Ronchetti, S., Guo, A., Ruggero, D., Pandolfi, P.P. Promyelocytic leukemia protein (PML) and daxx participate in a novel nuclear pathway for apoptosis.// J. Exp. Med. 2000 — v. 191, № 4 — P. 631−640.
- Zornig, M., Hueber, A.O., Evan, G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.// Curr. Biol. 1998 -v. 8, № 8-P. 467−470.
- Zou, H., Henzel, W.J., Liu, X., Lutschg, A., Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.// Cell 1997 — v. 90, № 3 — P. 405−413.
- Zou, H., Li, Y., Liu, X., Wang, X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.// J. Biol. Chem. -1999-v. 274,№ 17-P. 11 549−11 556.